Progress in understanding the pathogenesis underlying migraine has been made with
the identification of signaling molecules that are involved in the genesis of a migraine
attack. This advance has facilitated the development of mechanism-based therapies
for migraine. In my presentation I will review the current understanding of the pathogenesis
of migraine, which is based predominantly on clinical data published within the past
10 years, and outline recommended practices for the treatment of acute migraine and
for preventive treatment of migraine, emphasizing medications that have recently been
approved.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
